HEADER HYDROLASE 08-JUN-10 3NEG TITLE PYRABACTIN-BOUND PYL1 STRUCTURE IN THE OPEN AND CLOSE FORMS COMPND MOL_ID: 1; COMPND 2 MOLECULE: ABSCISIC ACID RECEPTOR PYL1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 20-221; COMPND 5 SYNONYM: PYL1, PYR1-LIKE PROTEIN 1, ABI1-BINDING PROTEIN 6, COMPND 6 REGULATORY COMPONENTS OF ABA RECEPTOR 9; COMPND 7 EC: 3.1.3.16; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ARABIDOPSIS THALIANA; SOURCE 3 ORGANISM_COMMON: MOUSE-EAR CRESS; SOURCE 4 ORGANISM_TAXID: 3702; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET-15B KEYWDS PYL1, PYRABACTIN, HORMONE RECEPTOR, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR N.YAN REVDAT 4 01-NOV-23 3NEG 1 REMARK REVDAT 3 15-SEP-10 3NEG 1 JRNL REVDAT 2 30-JUN-10 3NEG 1 JRNL REVDAT 1 16-JUN-10 3NEG 0 JRNL AUTH Q.HAO,P.YIN,C.YAN,X.YUAN,W.LI,Z.ZHANG,L.LIU,J.WANG,N.YAN JRNL TITL FUNCTIONAL MECHANISM OF THE ABA AGONIST PYRABACTIN JRNL REF J.BIOL.CHEM. V. 285 28946 2010 JRNL REFN ISSN 0021-9258 JRNL PMID 20554531 JRNL DOI 10.1074/JBC.M110.149005 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.6_289) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 69.50 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.300 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.0 REMARK 3 NUMBER OF REFLECTIONS : 38331 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1955 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 69.5242 - 6.7496 0.99 2809 128 0.1874 0.2346 REMARK 3 2 6.7496 - 5.3580 1.00 2762 180 0.1745 0.2442 REMARK 3 3 5.3580 - 4.6809 1.00 2796 148 0.1585 0.2108 REMARK 3 4 4.6809 - 4.2529 1.00 2780 158 0.1448 0.1933 REMARK 3 5 4.2529 - 3.9481 1.00 2780 150 0.1508 0.1883 REMARK 3 6 3.9481 - 3.7154 1.00 2816 127 0.1633 0.1996 REMARK 3 7 3.7154 - 3.5293 1.00 2795 151 0.1855 0.2301 REMARK 3 8 3.5293 - 3.3757 1.00 2806 152 0.1922 0.2309 REMARK 3 9 3.3757 - 3.2457 1.00 2788 149 0.2221 0.2443 REMARK 3 10 3.2457 - 3.1337 1.00 2771 147 0.2344 0.2855 REMARK 3 11 3.1337 - 3.0358 1.00 2790 148 0.2657 0.2973 REMARK 3 12 3.0358 - 2.9490 0.96 2658 151 0.2757 0.2886 REMARK 3 13 2.9490 - 2.8713 0.63 1741 124 0.2638 0.2720 REMARK 3 14 2.8713 - 2.8013 0.45 1284 42 0.2570 0.3130 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.34 REMARK 3 B_SOL : 46.27 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.400 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.930 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 61.52 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 86.23 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 13.00450 REMARK 3 B22 (A**2) : 13.00450 REMARK 3 B33 (A**2) : -26.00910 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 2967 REMARK 3 ANGLE : 1.198 4022 REMARK 3 CHIRALITY : 0.071 454 REMARK 3 PLANARITY : 0.004 522 REMARK 3 DIHEDRAL : 18.918 1080 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A REMARK 3 ORIGIN FOR THE GROUP (A): -56.5521 37.3130 -12.3824 REMARK 3 T TENSOR REMARK 3 T11: 0.3486 T22: 0.3101 REMARK 3 T33: 0.3432 T12: -0.0685 REMARK 3 T13: -0.0306 T23: -0.0344 REMARK 3 L TENSOR REMARK 3 L11: 2.7595 L22: 2.2074 REMARK 3 L33: 4.8094 L12: 0.1142 REMARK 3 L13: -0.1691 L23: 1.4579 REMARK 3 S TENSOR REMARK 3 S11: -0.1847 S12: -0.0792 S13: 0.0867 REMARK 3 S21: -0.0126 S22: 0.0761 S23: 0.0181 REMARK 3 S31: -0.0986 S32: 0.2493 S33: -0.0002 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN B REMARK 3 ORIGIN FOR THE GROUP (A): -43.4977 56.7306 3.2108 REMARK 3 T TENSOR REMARK 3 T11: 0.4208 T22: 0.7060 REMARK 3 T33: 0.5154 T12: -0.3990 REMARK 3 T13: -0.0718 T23: 0.0130 REMARK 3 L TENSOR REMARK 3 L11: 1.8839 L22: 1.7160 REMARK 3 L33: 4.2409 L12: 1.3233 REMARK 3 L13: -0.5813 L23: -0.1831 REMARK 3 S TENSOR REMARK 3 S11: 0.0369 S12: -0.0145 S13: -0.1662 REMARK 3 S21: 0.0003 S22: 0.2690 S23: -0.0514 REMARK 3 S31: -0.4160 S32: 0.6103 S33: -0.0003 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE FRIEDEL PAIRS WERE USED FOR REMARK 3 PHASING. REMARK 4 REMARK 4 3NEG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 09-JUN-10. REMARK 100 THE DEPOSITION ID IS D_1000059726. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-MAR-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.92001 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38331 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.801 REMARK 200 RESOLUTION RANGE LOW (A) : 69.503 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.1 REMARK 200 DATA REDUNDANCY : 6.000 REMARK 200 R MERGE (I) : 0.09500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 54.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.42200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3KDJ REMARK 200 REMARK 200 REMARK: THE STRUCTURE FACTOR FILE CONTAINS FRIEDEL PAIRS. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 73.44 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M CITRIC ACID PH 5.5, 0.01M REMARK 280 GSH/GSSG, 10% PEG 4000, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 29.41667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 58.83333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 58.83333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 29.41667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE A -1 REMARK 465 SER A 0 REMARK 465 THR A 1 REMARK 465 LEU A 2 REMARK 465 GLU A 138 REMARK 465 GLU A 139 REMARK 465 GLU A 140 REMARK 465 GLU A 141 REMARK 465 GLU A 142 REMARK 465 ASN A 190 REMARK 465 ASN A 191 REMARK 465 ASN A 192 REMARK 465 ASN A 193 REMARK 465 ASN A 194 REMARK 465 ASN A 195 REMARK 465 SER A 196 REMARK 465 SER A 197 REMARK 465 GLN A 198 REMARK 465 VAL A 199 REMARK 465 ARG A 200 REMARK 465 ILE B -1 REMARK 465 SER B 0 REMARK 465 THR B 1 REMARK 465 LEU B 2 REMARK 465 HIS B 3 REMARK 465 HIS B 4 REMARK 465 GLN B 5 REMARK 465 THR B 6 REMARK 465 MET B 7 REMARK 465 PRO B 8 REMARK 465 GLU B 138 REMARK 465 GLU B 139 REMARK 465 GLU B 140 REMARK 465 GLU B 141 REMARK 465 GLU B 142 REMARK 465 ARG B 143 REMARK 465 ASN B 192 REMARK 465 ASN B 193 REMARK 465 ASN B 194 REMARK 465 ASN B 195 REMARK 465 SER B 196 REMARK 465 SER B 197 REMARK 465 GLN B 198 REMARK 465 VAL B 199 REMARK 465 ARG B 200 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A 3 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 137 CG CD CE NZ REMARK 470 SER B 9 OG REMARK 470 GLU B 120 CG CD OE1 OE2 REMARK 470 HIS B 121 CG ND1 CD2 CE1 NE2 REMARK 470 ARG B 122 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 136 CG CD OE1 OE2 REMARK 470 LYS B 137 CG CD CE NZ REMARK 470 ASN B 191 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO B 94 C - N - CA ANGL. DEV. = 9.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 4 -148.25 -112.56 REMARK 500 HIS A 27 40.89 -106.03 REMARK 500 LEU A 31 -145.13 -95.27 REMARK 500 ASN A 33 60.38 62.00 REMARK 500 ARG A 57 78.08 -65.77 REMARK 500 TYR A 64 -23.37 -142.87 REMARK 500 HIS A 121 -179.87 -170.30 REMARK 500 PRO A 157 152.52 -49.01 REMARK 500 GLU A 158 -76.83 -35.26 REMARK 500 PHE A 168 -71.69 -51.74 REMARK 500 ASN A 188 -110.59 57.50 REMARK 500 ASP B 10 104.16 159.69 REMARK 500 MET B 79 92.72 -69.06 REMARK 500 PRO B 94 -128.02 -2.91 REMARK 500 ALA B 95 53.38 -114.87 REMARK 500 ARG B 110 76.82 64.10 REMARK 500 HIS B 121 42.69 -77.42 REMARK 500 LYS B 127 107.46 -162.49 REMARK 500 ASN B 190 0.64 -66.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PYV A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PYV B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BR A 202 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3KDH RELATED DB: PDB REMARK 900 APO-PYL2 REMARK 900 RELATED ID: 3KDI RELATED DB: PDB REMARK 900 (+)-ABA BOUND PYL2 REMARK 900 RELATED ID: 3KDJ RELATED DB: PDB REMARK 900 (+)-ABA-BOUND PYL1 AND ABI1 REMARK 900 RELATED ID: 3NEF RELATED DB: PDB REMARK 900 PYRABACTIN-BOUND PYL1 AT 2.4A DBREF 3NEG A -1 200 UNP Q8VZS8 PYL1_ARATH 20 221 DBREF 3NEG B -1 200 UNP Q8VZS8 PYL1_ARATH 20 221 SEQRES 1 A 202 ILE SER THR LEU HIS HIS GLN THR MET PRO SER ASP LEU SEQRES 2 A 202 THR GLN ASP GLU PHE THR GLN LEU SER GLN SER ILE ALA SEQRES 3 A 202 GLU PHE HIS THR TYR GLN LEU GLY ASN GLY ARG CYS SER SEQRES 4 A 202 SER LEU LEU ALA GLN ARG ILE HIS ALA PRO PRO GLU THR SEQRES 5 A 202 VAL TRP SER VAL VAL ARG ARG PHE ASP ARG PRO GLN ILE SEQRES 6 A 202 TYR LYS HIS PHE ILE LYS SER CYS ASN VAL SER GLU ASP SEQRES 7 A 202 PHE GLU MET ARG VAL GLY CYS THR ARG ASP VAL ASN VAL SEQRES 8 A 202 ILE SER GLY LEU PRO ALA ASN THR SER ARG GLU ARG LEU SEQRES 9 A 202 ASP LEU LEU ASP ASP ASP ARG ARG VAL THR GLY PHE SER SEQRES 10 A 202 ILE THR GLY GLY GLU HIS ARG LEU ARG ASN TYR LYS SER SEQRES 11 A 202 VAL THR THR VAL HIS ARG PHE GLU LYS GLU GLU GLU GLU SEQRES 12 A 202 GLU ARG ILE TRP THR VAL VAL LEU GLU SER TYR VAL VAL SEQRES 13 A 202 ASP VAL PRO GLU GLY ASN SER GLU GLU ASP THR ARG LEU SEQRES 14 A 202 PHE ALA ASP THR VAL ILE ARG LEU ASN LEU GLN LYS LEU SEQRES 15 A 202 ALA SER ILE THR GLU ALA MET ASN ARG ASN ASN ASN ASN SEQRES 16 A 202 ASN ASN SER SER GLN VAL ARG SEQRES 1 B 202 ILE SER THR LEU HIS HIS GLN THR MET PRO SER ASP LEU SEQRES 2 B 202 THR GLN ASP GLU PHE THR GLN LEU SER GLN SER ILE ALA SEQRES 3 B 202 GLU PHE HIS THR TYR GLN LEU GLY ASN GLY ARG CYS SER SEQRES 4 B 202 SER LEU LEU ALA GLN ARG ILE HIS ALA PRO PRO GLU THR SEQRES 5 B 202 VAL TRP SER VAL VAL ARG ARG PHE ASP ARG PRO GLN ILE SEQRES 6 B 202 TYR LYS HIS PHE ILE LYS SER CYS ASN VAL SER GLU ASP SEQRES 7 B 202 PHE GLU MET ARG VAL GLY CYS THR ARG ASP VAL ASN VAL SEQRES 8 B 202 ILE SER GLY LEU PRO ALA ASN THR SER ARG GLU ARG LEU SEQRES 9 B 202 ASP LEU LEU ASP ASP ASP ARG ARG VAL THR GLY PHE SER SEQRES 10 B 202 ILE THR GLY GLY GLU HIS ARG LEU ARG ASN TYR LYS SER SEQRES 11 B 202 VAL THR THR VAL HIS ARG PHE GLU LYS GLU GLU GLU GLU SEQRES 12 B 202 GLU ARG ILE TRP THR VAL VAL LEU GLU SER TYR VAL VAL SEQRES 13 B 202 ASP VAL PRO GLU GLY ASN SER GLU GLU ASP THR ARG LEU SEQRES 14 B 202 PHE ALA ASP THR VAL ILE ARG LEU ASN LEU GLN LYS LEU SEQRES 15 B 202 ALA SER ILE THR GLU ALA MET ASN ARG ASN ASN ASN ASN SEQRES 16 B 202 ASN ASN SER SER GLN VAL ARG HET PYV A 201 22 HET BR A 202 1 HET PYV B 201 22 HETNAM PYV 4-BROMO-N-(PYRIDIN-2-YLMETHYL)NAPHTHALENE-1-SULFONAMIDE HETNAM BR BROMIDE ION HETSYN PYV PYRABACTIN FORMUL 3 PYV 2(C16 H13 BR N2 O2 S) FORMUL 4 BR BR 1- FORMUL 6 HOH *2(H2 O) HELIX 1 1 THR A 12 HIS A 27 1 16 HELIX 2 2 PRO A 47 ARG A 56 1 10 HELIX 3 3 ARG A 60 TYR A 64 5 5 HELIX 4 4 SER A 161 ASN A 188 1 28 HELIX 5 5 THR B 12 HIS B 27 1 16 HELIX 6 6 PRO B 47 ARG B 56 1 10 HELIX 7 7 ARG B 60 TYR B 64 5 5 HELIX 8 8 SER B 161 ASN B 190 1 30 SHEET 1 A 7 ARG A 35 ILE A 44 0 SHEET 2 A 7 TRP A 145 ASP A 155 -1 O GLU A 150 N LEU A 40 SHEET 3 A 7 LYS A 127 PHE A 135 -1 N VAL A 129 O SER A 151 SHEET 4 A 7 VAL A 111 GLU A 120 -1 N THR A 112 O THR A 130 SHEET 5 A 7 THR A 97 ASP A 106 -1 N ASP A 103 O GLY A 113 SHEET 6 A 7 THR A 84 VAL A 89 -1 N VAL A 87 O SER A 98 SHEET 7 A 7 ILE A 68 ASN A 72 -1 N SER A 70 O ASN A 88 SHEET 1 B 7 ARG B 35 ILE B 44 0 SHEET 2 B 7 TRP B 145 ASP B 155 -1 O GLU B 150 N LEU B 40 SHEET 3 B 7 LYS B 127 PHE B 135 -1 N THR B 131 O LEU B 149 SHEET 4 B 7 VAL B 111 GLY B 118 -1 N THR B 112 O THR B 130 SHEET 5 B 7 THR B 97 ASP B 106 -1 N ARG B 99 O GLY B 118 SHEET 6 B 7 THR B 84 VAL B 89 -1 N ARG B 85 O GLU B 100 SHEET 7 B 7 ILE B 68 ASN B 72 -1 N SER B 70 O ASN B 88 CISPEP 1 THR A 117 GLY A 118 0 -13.99 CISPEP 2 ASP B 10 LEU B 11 0 -1.49 SITE 1 AC1 11 LYS A 65 ILE A 68 VAL A 87 ALA A 95 SITE 2 AC1 11 SER A 98 GLU A 100 HIS A 121 LEU A 123 SITE 3 AC1 11 TYR A 126 VAL A 172 HOH A 203 SITE 1 AC2 11 VAL B 87 VAL B 89 SER B 98 GLU B 100 SITE 2 AC2 11 PHE B 114 ILE B 116 GLU B 120 LEU B 123 SITE 3 AC2 11 PHE B 168 VAL B 172 ILE B 173 SITE 1 AC3 2 PRO A 94 ARG A 122 CRYST1 130.230 130.230 88.250 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007679 0.004433 0.000000 0.00000 SCALE2 0.000000 0.008867 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011331 0.00000